These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 1118074)

  • 21. [Drug therapy in blood coagulation disorders].
    Markwardt F
    Zentralbl Chir; 1975; 100(22):1345-51. PubMed ID: 1202856
    [No Abstract]   [Full Text] [Related]  

  • 22. Oxandrolone steroid use and impaired coagulation.
    Koller EA; Wei X; Johnson TE
    Arch Intern Med; 2006 Jan; 166(1):125. PubMed ID: 16401821
    [No Abstract]   [Full Text] [Related]  

  • 23. [Management of blood coagulation disorders].
    Porchia NL
    Matern Infanc (Sao Paulo); 1968; 27(4):349-55. PubMed ID: 5728525
    [No Abstract]   [Full Text] [Related]  

  • 24. [Use of antifibrinolytic agents in obstetrics].
    Vojta M
    Cesk Gynekol; 1970 Jul; 35(6):384-6. PubMed ID: 5311001
    [No Abstract]   [Full Text] [Related]  

  • 25. [On differential therapy with antifibrinolytic agents].
    Marx R; Matis P; Mayer W; Weinzierl M
    Med Welt; 1968 Apr; 17():1134-8. PubMed ID: 5303822
    [No Abstract]   [Full Text] [Related]  

  • 26. [Comparative biochemical studies on transurethral and transvesical prostatectomy. 3. Changes of blood coagulation following surgical intervention of the prostate].
    Naber K; Müller K; Bichler KH; Sommerkamp H; Jöhrens H; Porzsolt F
    Bruns Beitr Klin Chir (1971); 1973 Oct; 220(6):609-19. PubMed ID: 4766121
    [No Abstract]   [Full Text] [Related]  

  • 27. [Changes of blood coagulation in prostatic surgery, consequences for preventive therapy with antifibrinolytic agents].
    Naber K; Bichler KH; Müller KH; Sommerkamp H; Jöhrens H; Porzsolt F
    Helv Chir Acta; 1973 Sep; 40(4):519-22. PubMed ID: 4753393
    [No Abstract]   [Full Text] [Related]  

  • 28. [Antifibrinolytic agents and anticoagulants in disseminated intravascular coagulation, with particular regard to embolism of the amniotic fluid and hemorrhage in gynecology].
    Koutský J
    Cesk Gynekol; 1971 Apr; 36(3):140-1. PubMed ID: 5314511
    [No Abstract]   [Full Text] [Related]  

  • 29. [Congenital blood coagulation disorders].
    Favre-Gilly J
    Lyon Med; 1972 Apr; 19():Suppl:119-31. PubMed ID: 4641427
    [No Abstract]   [Full Text] [Related]  

  • 30. Hemostatic drugs.
    Mannucci PM
    N Engl J Med; 1998 Jul; 339(4):245-53. PubMed ID: 9673304
    [No Abstract]   [Full Text] [Related]  

  • 31. [Prophylactic treatment in obstetric hypocoagulability].
    Corral FS; González S; Inocente JM
    Rev Clin Inst Matern Lisb; 1967; 18(70):225-32. PubMed ID: 5631944
    [No Abstract]   [Full Text] [Related]  

  • 32. Prevention and treatment of major blood loss.
    Mannucci PM; Levi M
    N Engl J Med; 2007 May; 356(22):2301-11. PubMed ID: 17538089
    [No Abstract]   [Full Text] [Related]  

  • 33. Trasylol therapy of haemorrhage in surgical patients.
    Amris CJ
    Acta Chir Scand Suppl; 1967; 378():45-52. PubMed ID: 5300106
    [No Abstract]   [Full Text] [Related]  

  • 34. Antifibrinolytic agents in acquired bleeding disorders.
    Walsh M
    Clin Adv Hematol Oncol; 2017 May; 15(5):357-361. PubMed ID: 28591091
    [No Abstract]   [Full Text] [Related]  

  • 35. Case report: Glanzmann thrombasthenia. Dental patient management for a rare platelet disorder.
    Cohen HV; Wu P
    J N J Dent Assoc; 2005; 76(3):17-8. PubMed ID: 16320915
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Congestive Mediterranean splenomegaly and consummation coagulopathy. I. General characteristics of blood coagulation disorders observed in Mediterranean splenomegaly].
    Demange J; Berbich A; Hassar ; Maouni ; tTazi-Moha ; Tounsi
    Ann Med Interne (Paris); 1969 Dec; 120(12):827-33. PubMed ID: 5377663
    [No Abstract]   [Full Text] [Related]  

  • 37. [Defibrination syndrome: treatment with an antifibrinolytic drug and anticoagulants].
    Mannucci PM; Lobina G; Biggio P; Caocci L; Congiu P
    Clin Ter; 1967 Oct; 43(1):19-33. PubMed ID: 4884577
    [No Abstract]   [Full Text] [Related]  

  • 38. Management of the hereditary coagulation disorders.
    Mason DY; Ingram GI
    Semin Hematol; 1971 Apr; 8(2):158-88. PubMed ID: 5313347
    [No Abstract]   [Full Text] [Related]  

  • 39. [The pathogenesis and treatment of the hemostatic disorder in acute promyelocytic leukemia].
    Velasco F; López-Pedrera R; Páramo JA
    Med Clin (Barc); 1996 Jun; 107(2):59-61. PubMed ID: 8753897
    [No Abstract]   [Full Text] [Related]  

  • 40. [Experimental studies and clinical observations on the antifibrinolytic and hemostyptic effect of Epsilon-Tachostypan].
    Egli H; Schröder F
    Dtsch Zahn Mund Kieferheilkd Zentralbl Gesamte; 1968 May; 50(9):386-404. PubMed ID: 5252696
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.